We explore the immense potential of gamma delta T cells, and the challenges in sourcing and scaling up sufficient volumes to ...

Boston Scientific temporarily paused enrolment in its AVANT GUARD trial in October to “assess a few unanticipated ...

RAPT Therapeutics’ CEO Brian Wong said there was no “viable path forward” for the compound. Image credit: Shutterstock/Andrii Yalanskyi. RAPT Therapeutics has called it quits on a clinical programme ...

Paratek’s Nuzyra is approved by the US Food and Drug Administration (FDA) as a treatment for community-acquired bacterial pneumonia (CABP) and acute bacterial skin and skin structure infections ...

The funding is set to support the initiation various trials of its assets. Credit: SOMKID THONGDEE/Shutterstock. Disc Medicine (Disc) has secured a $200m non-dilutive term loan facility from Hercules ...

The companies’ monoclonal antibody met co-primary endpoints in a Phase III trial in patients with chronic rhinosinusitis with ...

Radella Pharmaceuticals has reported topline outcomes from a Phase Ia trial that assessed an investigational therapy for ...

Also known as a polymyxin B haemoperfusion (PMX), Toraymyxin is a haemoperfusion device that removes endotoxin, a toxic ...

The field of atopic dermatitis (AD) has been receiving great interest over the last few years with the approvals of both oral ...

The former health minister predicted a bright future for UK trials and outlined steps to ensure clinical research thrives.

Research Grid has raised a $6.5m seed funding round led by Fuel Ventures, to improve the success rate of clinical trials.

Lord Vallance stated the government sees investment, innovation, and public-private partnership as crucial to UK healthcare.